Tcr2 Therapeutics Price History
| TCRRDelisted Stock | USD 1.48 0.00 0.00% |
If you're considering investing in Tcr2 Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tcr2 Therapeutics stands at 1.48, as last reported on the 26th of November, with the highest price reaching 1.48 and the lowest price hitting 1.48 during the day. We have found twenty-five technical indicators for Tcr2 Therapeutics, which you can use to evaluate the volatility of the company. Please validate Tcr2 Therapeutics' Coefficient Of Variation of 1404.52, risk adjusted performance of 0.0632, and Semi Deviation of 3.26 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Tcr2 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Tcr2 |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TCRR |
Based on monthly moving average Tcr2 Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tcr2 Therapeutics by adding Tcr2 Therapeutics to a well-diversified portfolio.
Tcr2 Therapeutics Stock Price History Chart
There are several ways to analyze Tcr2 Stock price data. The simplest method is using a basic Tcr2 candlestick price chart, which shows Tcr2 Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Tcr2 Stock Price History Data
The price series of Tcr2 Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.78 with a coefficient of variation of 12.49. The price distribution for the period has arithmetic mean of 1.63. The median price for the last 90 days is 1.57.| Open | High | Low | Close | Volume | ||
11/26/2024 | 1.48 | 1.48 | 1.48 | 1.48 | ||
| 06/01/2023 | 1.48 | 1.48 | 1.48 | 1.48 | 1.00 | |
| 05/31/2023 | 1.58 | 1.63 | 1.48 | 1.48 | 3,913,300 | |
| 05/30/2023 | 1.62 | 1.62 | 1.50 | 1.57 | 388,600 | |
| 05/26/2023 | 1.73 | 1.75 | 1.56 | 1.58 | 538,350 | |
| 05/25/2023 | 1.71 | 1.77 | 1.64 | 1.75 | 376,441 | |
| 05/24/2023 | 1.72 | 1.78 | 1.65 | 1.75 | 391,200 | |
| 05/23/2023 | 1.78 | 1.86 | 1.73 | 1.73 | 395,233 | |
| 05/22/2023 | 1.88 | 1.92 | 1.81 | 1.82 | 242,500 | |
| 05/19/2023 | 1.87 | 1.92 | 1.85 | 1.88 | 77,200 | |
| 05/18/2023 | 1.88 | 1.94 | 1.83 | 1.88 | 133,000 | |
| 05/17/2023 | 1.83 | 1.91 | 1.78 | 1.86 | 292,376 | |
| 05/16/2023 | 1.96 | 1.96 | 1.86 | 1.88 | 167,400 | |
| 05/15/2023 | 1.93 | 2.01 | 1.93 | 1.95 | 422,169 | |
| 05/12/2023 | 2.00 | 2.00 | 1.92 | 1.96 | 215,200 | |
| 05/11/2023 | 1.94 | 1.99 | 1.92 | 1.96 | 166,100 | |
| 05/10/2023 | 2.00 | 2.03 | 1.94 | 1.98 | 154,900 | |
| 05/09/2023 | 1.97 | 2.01 | 1.91 | 1.98 | 192,900 | |
| 05/08/2023 | 2.01 | 2.04 | 1.94 | 1.96 | 425,536 | |
| 05/05/2023 | 1.89 | 1.96 | 1.86 | 1.95 | 361,000 | |
| 05/04/2023 | 1.80 | 1.90 | 1.79 | 1.88 | 305,559 | |
| 05/03/2023 | 1.78 | 1.89 | 1.78 | 1.83 | 285,578 | |
| 05/02/2023 | 1.79 | 1.85 | 1.77 | 1.79 | 163,990 | |
| 05/01/2023 | 1.78 | 1.88 | 1.78 | 1.84 | 458,000 | |
| 04/28/2023 | 1.75 | 1.83 | 1.71 | 1.77 | 220,347 | |
| 04/27/2023 | 1.80 | 1.82 | 1.76 | 1.77 | 166,400 | |
| 04/26/2023 | 1.78 | 1.84 | 1.77 | 1.81 | 94,284 | |
| 04/25/2023 | 1.75 | 1.82 | 1.71 | 1.77 | 220,700 | |
| 04/24/2023 | 1.71 | 1.86 | 1.71 | 1.82 | 461,100 | |
| 04/21/2023 | 1.68 | 1.75 | 1.61 | 1.73 | 399,904 | |
| 04/20/2023 | 1.78 | 1.79 | 1.69 | 1.69 | 212,500 | |
| 04/19/2023 | 1.56 | 1.75 | 1.56 | 1.74 | 275,300 | |
| 04/18/2023 | 1.61 | 1.65 | 1.60 | 1.63 | 263,300 | |
| 04/17/2023 | 1.55 | 1.76 | 1.55 | 1.65 | 360,919 | |
| 04/14/2023 | 1.50 | 1.60 | 1.50 | 1.56 | 294,600 | |
| 04/13/2023 | 1.52 | 1.56 | 1.48 | 1.51 | 381,600 | |
| 04/12/2023 | 1.56 | 1.57 | 1.51 | 1.54 | 99,700 | |
| 04/11/2023 | 1.45 | 1.60 | 1.45 | 1.54 | 250,645 | |
| 04/10/2023 | 1.44 | 1.49 | 1.43 | 1.47 | 130,300 | |
| 04/06/2023 | 1.44 | 1.51 | 1.43 | 1.47 | 340,070 | |
| 04/05/2023 | 1.44 | 1.46 | 1.40 | 1.43 | 143,003 | |
| 04/04/2023 | 1.51 | 1.53 | 1.43 | 1.45 | 178,254 | |
| 04/03/2023 | 1.49 | 1.54 | 1.47 | 1.50 | 486,100 | |
| 03/31/2023 | 1.45 | 1.50 | 1.45 | 1.50 | 160,000 | |
| 03/30/2023 | 1.45 | 1.50 | 1.44 | 1.44 | 98,220 | |
| 03/29/2023 | 1.46 | 1.49 | 1.43 | 1.45 | 90,735 | |
| 03/28/2023 | 1.48 | 1.50 | 1.45 | 1.46 | 166,100 | |
| 03/27/2023 | 1.50 | 1.52 | 1.45 | 1.51 | 126,300 | |
| 03/24/2023 | 1.36 | 1.52 | 1.36 | 1.50 | 241,400 | |
| 03/23/2023 | 1.52 | 1.52 | 1.35 | 1.42 | 326,301 | |
| 03/22/2023 | 1.52 | 1.57 | 1.46 | 1.47 | 169,972 | |
| 03/21/2023 | 1.44 | 1.55 | 1.41 | 1.54 | 312,600 | |
| 03/20/2023 | 1.47 | 1.50 | 1.43 | 1.45 | 235,785 | |
| 03/17/2023 | 1.51 | 1.54 | 1.44 | 1.46 | 415,164 | |
| 03/16/2023 | 1.48 | 1.64 | 1.46 | 1.56 | 308,246 | |
| 03/15/2023 | 1.51 | 1.53 | 1.44 | 1.49 | 127,370 | |
| 03/14/2023 | 1.45 | 1.54 | 1.43 | 1.51 | 312,186 | |
| 03/13/2023 | 1.40 | 1.48 | 1.36 | 1.43 | 340,179 | |
| 03/10/2023 | 1.53 | 1.54 | 1.38 | 1.43 | 731,029 | |
| 03/09/2023 | 1.56 | 1.61 | 1.51 | 1.56 | 585,698 | |
| 03/08/2023 | 1.62 | 1.64 | 1.54 | 1.55 | 1,021,400 |
About Tcr2 Therapeutics Stock history
Tcr2 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tcr2 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tcr2 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tcr2 Therapeutics stock prices may prove useful in developing a viable investing in Tcr2 Therapeutics
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor therapies for patients suffering from cancer. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Tcr2 Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.
Tcr2 Therapeutics Stock Technical Analysis
Tcr2 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Tcr2 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tcr2 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tcr2 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tcr2 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0632 | |||
| Jensen Alpha | 0.4618 | |||
| Total Risk Alpha | (0.48) | |||
| Sortino Ratio | 0.0653 | |||
| Treynor Ratio | (0.54) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Tcr2 Stock
If you are still planning to invest in Tcr2 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tcr2 Therapeutics' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |